Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,865.00    0.00 (0.00%)
Bid:
2,855.00
Ask:
2,860.00
Spread: 5.00 (0.175%)
Market Cap: £2.24b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

27 May 2026 15:01

RNS Number : 9325F
Hill & Smith PLC
27 May 2026
 

 

Hill & Smith PLC

(the 'Company' or 'Hill & Smith')

 

Director / PDMR Shareholding

 

Hill & Smith announces that on 26 May 2026, it was notified of the exercise and subsequent sale by Chris McLeish, Chief Financial Officer of Shares under his 2023 Deferred Bonus Buy-Out Award.

 

The Notification of Dealing Form can be found below:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Chris McLeish

2.

Reason for the notification

(a)

Position/status

Chief Financial Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Acquisition of Ordinary Shares pursuant to the exercise of an award under his 2023 Deferred Bonus Buy-Out Award.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

 

5,690

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

Outside of a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary Shares of £0.25 each

(b)

Identification code of the Financial Instrument

GB0004270301

(c)

Nature of the transaction

Sale of Ordinary Shares to cover tax and NI liability on the exercise of awards outlined in 4.1.

(d)

Price(s) and volume(s)

Price(s)

Volume(s)

£27.60

 

2,682

(e)

Aggregated information

N/A

- Aggregated volume

- Price

(f)

Date of the transaction

26 May 2026

(g)

Place of the transaction

XLON

 

Enquiries:

 

Karen Atterbury

Company Secretary

0121 704 7430

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHAKOBKQBKDKPB
Date   Source Headline
1st Apr 20257:00 amRNSTotal Voting Rights
26th Mar 20253:50 pmRNSDirector/PDMR Shareholding
25th Mar 20257:00 amRNSBoard Appointment
24th Mar 20253:58 pmRNSTransaction in Own Shares
20th Mar 20252:06 pmRNSHolding(s) in Company
19th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 202512:56 pmRNSDirector/PDMR Shareholding
14th Mar 20252:28 pmRNSDirector/PDMR Shareholding
13th Mar 20251:09 pmRNSDirector/PDMR Shareholding
12th Mar 20257:00 amRNSFull Year Results
6th Mar 20257:00 amRNSHolding(s) in Company
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTotal Voting Rights
22nd Jan 20257:44 amRNSBlock listing Interim Review
7th Jan 20257:00 amRNSDirectorate Change
2nd Jan 20257:00 amRNSTotal Voting Rights
10th Dec 202410:06 amRNSHolding(s) in Company
2nd Dec 20247:00 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSTrading Statement
1st Nov 20247:00 amRNSTotal Voting Rights
11th Oct 20243:27 pmRNSHolding(s) in Company
11th Oct 20242:05 pmRNSDirector/PDMR Shareholding
1st Oct 20247:30 amRNSTotal Voting Rights
26th Sep 20249:00 amRNSDirector/PDMR Shareholding
20th Sep 202410:57 amRNSDirector/PDMR Shareholding
19th Sep 20247:00 amRNSDirectorate Changes
10th Sep 20247:00 amRNSAcquisition of Whitlow Electric
2nd Sep 20248:55 amRNSTotal Voting Rights
14th Aug 20249:56 amRNSHolding(s) in Company
8th Aug 20247:01 amRNSAcquisition of Trident Industries
8th Aug 20247:00 amRNSHalf Year Results
7th Aug 20249:06 amRNSHolding(s) in Company
1st Aug 20247:30 amRNSTotal Voting Rights
22nd Jul 202410:15 amRNSBlock listing Interim Review
1st Jul 20249:10 amRNSTotal Voting Rights
19th Jun 20248:04 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20241:39 pmRNSResult of AGM
23rd May 20247:01 amRNSAppointment of Joint Corporate Broker
23rd May 20247:00 amRNSAGM Statement
15th May 20249:25 amRNSHolding(s) in Company
1st May 20248:45 amRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20249:13 amRNSTransaction in Own Shares
26th Apr 202411:36 amRNSTransaction in Own Shares
24th Apr 202410:38 amRNSTransaction in Own Shares
22nd Apr 202412:29 pmRNSTransaction in Own Shares
19th Apr 20247:25 amRNSNotice of AGM
18th Apr 20249:21 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.